Opoku, Y. K. (2020) “Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells”, EXCLI Journal, 19, pp. 567–581. doi: 10.17179/excli2020-1287.